Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphomaRichard A. Noble(Newcastle University), Stephen R. Wedge(Newcastle University)British Journal of CancerMay 26, 202210.1038/s41416-022-01848-wCited by 48SaveCiteExport RISWatch citationsRelated PapersAZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer|Cancer Research|2005|710The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) Enhances the Radiation Responsiveness of Lung and Colorectal Tumor Xenografts|Clinical Cancer Research|2009|51